{"date":"2026-04-14","count":33,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-7888-2026-04-14-2356-3sk96k","company_id":"7888","company":"麗寶新藥","market":"興櫃","industry":"生技醫療","date":"2026-04-14","time":"23:56:17","subject":"公告本公司董事會決議發行限制員工權利新股","clause":"第9款","fact_date":"2026-04-14","cite_as":"公開資訊觀測站重大訊息：麗寶新藥（7888），2026-04-14 23:56，「公告本公司董事會決議發行限制員工權利新股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4190-2026-04-14-1957-3y2rvt","company_id":"4190","company":"佐登-KY","market":"上市","industry":"生技醫療","date":"2026-04-14","time":"19:57:06","subject":"代子公司佐登妮絲國際股份有限公司依公開發行公司資金貸與及背書保證處理準則第二十五條第一項第四款之規定公告","clause":"第22款","fact_date":"2026-04-14","cite_as":"公開資訊觀測站重大訊息：佐登-KY（4190），2026-04-14 19:57，「代子公司佐登妮絲國際股份有限公司依公開發行公司資金貸與及背書保證處理準則第二十五條第一項第四款之規定公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7888-2026-04-14-1946-5flzk1","company_id":"7888","company":"麗寶新藥","market":"興櫃","industry":"生技醫療","date":"2026-04-14","time":"19:46:46","subject":"公告本公司董事會決議召開115年股東常會相關事宜(新增議案)","clause":"第32款","fact_date":"2026-04-14","cite_as":"公開資訊觀測站重大訊息：麗寶新藥（7888），2026-04-14 19:46，「公告本公司董事會決議召開115年股東常會相關事宜(新增議案)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7850-2026-04-14-1942-8www2v","company_id":"7850","company":"寶泰生醫","market":"興櫃","industry":"生技醫療","date":"2026-04-14","time":"19:42:32","subject":"本公司受邀參加寬量國際主辦之「19th QIC CEO Week」","clause":"第30款","fact_date":"2026-04-15","cite_as":"公開資訊觀測站重大訊息：寶泰生醫（7850），2026-04-14 19:42，「本公司受邀參加寬量國際主辦之「19th QIC CEO Week」」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6810-2026-04-14-1910-1iqwxho","company_id":"6810","company":"新穎生醫","market":"興櫃","industry":"生技醫療","date":"2026-04-14","time":"19:10:58","subject":"公告本公司董事會決議召開115年股東常會事宜(異動召集事由)","clause":"第32款","fact_date":"2026-04-14","cite_as":"公開資訊觀測站重大訊息：新穎生醫（6810），2026-04-14 19:10，「公告本公司董事會決議召開115年股東常會事宜(異動召集事由)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6703-2026-04-14-1852-1shsaqf","company_id":"6703","company":"軒郁","market":"上櫃","industry":"生技醫療","date":"2026-04-14","time":"18:52:10","subject":"公告本公司董事會決議辦理私募現金增資發行新股","clause":"第11款","fact_date":"2026-04-14","cite_as":"公開資訊觀測站重大訊息：軒郁（6703），2026-04-14 18:52，「公告本公司董事會決議辦理私募現金增資發行新股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6703-2026-04-14-1842-1y3tymj","company_id":"6703","company":"軒郁","market":"上櫃","industry":"生技醫療","date":"2026-04-14","time":"18:42:27","subject":"公告本公司董事會決議召開115年度股東常會(增列議案)","clause":"第17款","fact_date":"2026-04-14","cite_as":"公開資訊觀測站重大訊息：軒郁（6703），2026-04-14 18:42，「公告本公司董事會決議召開115年度股東常會(增列議案)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7729-2026-04-14-1834-8yaj8l","company_id":"7729","company":"仲恩生醫","market":"興櫃","industry":"生技醫療","date":"2026-04-14","time":"18:34:21","subject":"公告本公司115年第一次現金增資基準日暨相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：仲恩生醫（7729），2026-04-14 18:34，「公告本公司115年第一次現金增資基準日暨相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4190-2026-04-14-1817-xjz3ab","company_id":"4190","company":"佐登-KY","market":"上市","industry":"生技醫療","date":"2026-04-14","time":"18:17:20","subject":"本公司董事會決議召開115年股東常會(增列報告事項第六案)","clause":"第17款","fact_date":"2026-04-14","cite_as":"公開資訊觀測站重大訊息：佐登-KY（4190），2026-04-14 18:17，「本公司董事會決議召開115年股東常會(增列報告事項第六案)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6610-2026-04-14-1811-1nnjec6","company_id":"6610","company":"安成生技","market":"興櫃","industry":"生技醫療","date":"2026-04-14","time":"18:11:58","subject":"公告本公司用於治療單純型遺傳性表皮分解性水皰症(EBS)之新藥 AC-203全球第二/三期人體臨床試驗已完成收案。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：安成生技（6610），2026-04-14 18:11，「公告本公司用於治療單純型遺傳性表皮分解性水皰症(EBS)之新藥 AC-203全球第二/三期人體臨床試驗已完成收案。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4190-2026-04-14-1807-sirs9x","company_id":"4190","company":"佐登-KY","market":"上市","industry":"生技醫療","date":"2026-04-14","time":"18:07:06","subject":"本公司董事會決議發行中華民國境內第四次有擔保轉換公司債","clause":"第11款","fact_date":"2026-04-14","cite_as":"公開資訊觀測站重大訊息：佐登-KY（4190），2026-04-14 18:07，「本公司董事會決議發行中華民國境內第四次有擔保轉換公司債」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4745-2026-04-14-1803-1gyc70x","company_id":"4745","company":"合富-KY","market":"上櫃","industry":"生技醫療","date":"2026-04-14","time":"18:03:07","subject":"公告本公司第二次買回庫藏股執行結果","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合富-KY（4745），2026-04-14 18:03，「公告本公司第二次買回庫藏股執行結果」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4163-2026-04-14-1737-rxx7eg","company_id":"4163","company":"鐿鈦","market":"上櫃","industry":"生技醫療","date":"2026-04-14","time":"17:37:56","subject":"公告本公司註銷收回限制員工權利新股辦理變更登記完成","clause":"第36款","fact_date":"2026-04-14","cite_as":"公開資訊觀測站重大訊息：鐿鈦（4163），2026-04-14 17:37，「公告本公司註銷收回限制員工權利新股辦理變更登記完成」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7803-2026-04-14-1715-1gtyn8c","company_id":"7803","company":"雲象科技-創","market":"上市","industry":"生技醫療","date":"2026-04-14","time":"17:15:39","subject":"公告臺灣證券交易所同意本公司申請延長股票上市買賣開始期限","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：雲象科技-創（7803），2026-04-14 17:15，「公告臺灣證券交易所同意本公司申請延長股票上市買賣開始期限」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1784-2026-04-14-1710-1gaipuo","company_id":"1784","company":"訊聯","market":"上櫃","industry":"生技醫療","date":"2026-04-14","time":"17:10:45","subject":"衛福部核准秀傳醫療財團法人秀傳紀念醫院與本公司合作之「自體脂肪幹細胞治療退化性關節炎及膝關節軟骨缺損」細胞治療技術施行計畫","clause":"第53款","fact_date":"2026-04-14","cite_as":"公開資訊觀測站重大訊息：訊聯（1784），2026-04-14 17:10，「衛福部核准秀傳醫療財團法人秀傳紀念醫院與本公司合作之「自體脂肪幹細胞治療退化性關節炎及膝關節軟骨缺損」細胞治療技術施行計」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4114-2026-04-14-1703-15go8qk","company_id":"4114","company":"健喬","market":"上櫃","industry":"生技醫療","date":"2026-04-14","time":"17:03:02","subject":"本公司董事會決議通過授權董事長洽談股權購買事宜","clause":"第20款","fact_date":"2026-04-14","cite_as":"公開資訊觀測站重大訊息：健喬（4114），2026-04-14 17:03，「本公司董事會決議通過授權董事長洽談股權購買事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4114-2026-04-14-1659-3sk96k","company_id":"4114","company":"健喬","market":"上櫃","industry":"生技醫療","date":"2026-04-14","time":"16:59:54","subject":"公告本公司董事會決議發行限制員工權利新股","clause":"第11款","fact_date":"2026-04-14","cite_as":"公開資訊觀測站重大訊息：健喬（4114），2026-04-14 16:59，「公告本公司董事會決議發行限制員工權利新股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4114-2026-04-14-1646-13bqai2","company_id":"4114","company":"健喬","market":"上櫃","industry":"生技醫療","date":"2026-04-14","time":"16:46:15","subject":"本公司董事會決議股利分派","clause":"第14款","fact_date":"2026-04-14","cite_as":"公開資訊觀測站重大訊息：健喬（4114），2026-04-14 16:46，「本公司董事會決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4114-2026-04-14-1640-160sqp9","company_id":"4114","company":"健喬","market":"上櫃","industry":"生技醫療","date":"2026-04-14","time":"16:40:37","subject":"本公司董事會通過召集115年股東常會相關事宜(增列討論事項)","clause":"第17款","fact_date":"2026-04-14","cite_as":"公開資訊觀測站重大訊息：健喬（4114），2026-04-14 16:40，「本公司董事會通過召集115年股東常會相關事宜(增列討論事項)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4114-2026-04-14-1628-upzbnp","company_id":"4114","company":"健喬","market":"上櫃","industry":"生技醫療","date":"2026-04-14","time":"16:28:55","subject":"公告本公司董事會決議盈餘暨資本公積轉增資發行新股","clause":"第11款","fact_date":"2026-04-14","cite_as":"公開資訊觀測站重大訊息：健喬（4114），2026-04-14 16:28，「公告本公司董事會決議盈餘暨資本公積轉增資發行新股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4114-2026-04-14-1623-itqmci","company_id":"4114","company":"健喬","market":"上櫃","industry":"生技醫療","date":"2026-04-14","time":"16:23:25","subject":"公告本公司董事會決議庫藏股轉讓員工並訂定認股基準日","clause":"第53款","fact_date":"2026-04-14","cite_as":"公開資訊觀測站重大訊息：健喬（4114），2026-04-14 16:23，「公告本公司董事會決議庫藏股轉讓員工並訂定認股基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3716-2026-04-14-1559-1bbj31","company_id":"3716","company":"中化控股","market":"上市","industry":"生技醫療","date":"2026-04-14","time":"15:59:40","subject":"本公司召開115年股東常會相關事宜。 (討論事項更正)","clause":"第17款","fact_date":"2026-03-05","cite_as":"公開資訊觀測站重大訊息：中化控股（3716），2026-04-14 15:59，「本公司召開115年股東常會相關事宜。 (討論事項更正)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4123-2026-04-14-1546-zcu497","company_id":"4123","company":"晟德","market":"上櫃","industry":"生技醫療","date":"2026-04-14","time":"15:46:00","subject":"公告本公司國內第八次無擔保轉換公司債暨第九次無擔保轉換公司債代收價款行庫及存儲專戶行庫","clause":"第53款","fact_date":"2026-04-14","cite_as":"公開資訊觀測站重大訊息：晟德（4123），2026-04-14 15:46，「公告本公司國內第八次無擔保轉換公司債暨第九次無擔保轉換公司債代收價款行庫及存儲專戶行庫」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6491-2026-04-14-1507-fw040o","company_id":"6491","company":"晶碩","market":"上市","industry":"生技醫療","date":"2026-04-14","time":"15:07:40","subject":"本公司股份買回計畫執行完畢","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：晶碩（6491），2026-04-14 15:07，「本公司股份買回計畫執行完畢」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6543-2026-04-14-1505-cb4icq","company_id":"6543","company":"普惠醫工","market":"興櫃","industry":"生技醫療","date":"2026-04-14","time":"15:05:45","subject":"更正本公司115年3月份資金貸與資訊揭露明細表","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：普惠醫工（6543），2026-04-14 15:05，「更正本公司115年3月份資金貸與資訊揭露明細表」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4123-2026-04-14-1455-1b6odvk","company_id":"4123","company":"晟德","market":"上櫃","industry":"生技醫療","date":"2026-04-14","time":"14:55:53","subject":"本公司董事會決議召開115年股東常會(新增議案)","clause":"第17款","fact_date":"2026-04-14","cite_as":"公開資訊觀測站重大訊息：晟德（4123），2026-04-14 14:55，「本公司董事會決議召開115年股東常會(新增議案)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4123-2026-04-14-1455-1h4hurr","company_id":"4123","company":"晟德","market":"上櫃","industry":"生技醫療","date":"2026-04-14","time":"14:55:35","subject":"公告本公司董事會決議辦理私募現金增資發行普通股","clause":"第11款","fact_date":"2026-04-14","cite_as":"公開資訊觀測站重大訊息：晟德（4123），2026-04-14 14:55，「公告本公司董事會決議辦理私募現金增資發行普通股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4123-2026-04-14-1455-1klkxka","company_id":"4123","company":"晟德","market":"上櫃","industry":"生技醫療","date":"2026-04-14","time":"14:55:21","subject":"本公司董事會決議不繼續辦理114年股東常會通過之私募普通股案","clause":"第16款","fact_date":"2026-04-14","cite_as":"公開資訊觀測站重大訊息：晟德（4123），2026-04-14 14:55，「本公司董事會決議不繼續辦理114年股東常會通過之私募普通股案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4123-2026-04-14-1455-17aa6cr","company_id":"4123","company":"晟德","market":"上櫃","industry":"生技醫療","date":"2026-04-14","time":"14:55:06","subject":"本公司董事會決議盈餘轉增資發行新股","clause":"第11款","fact_date":"2026-04-14","cite_as":"公開資訊觀測站重大訊息：晟德（4123），2026-04-14 14:55，「本公司董事會決議盈餘轉增資發行新股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4123-2026-04-14-1454-13bqai2","company_id":"4123","company":"晟德","market":"上櫃","industry":"生技醫療","date":"2026-04-14","time":"14:54:53","subject":"本公司董事會決議股利分派","clause":"第14款","fact_date":"2026-04-14","cite_as":"公開資訊觀測站重大訊息：晟德（4123），2026-04-14 14:54，「本公司董事會決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6492-2026-04-14-1420-1tn8yz8","company_id":"6492","company":"生華科","market":"上櫃","industry":"生技醫療","date":"2026-04-14","time":"14:20:22","subject":"本公司與GEM YIELD BAHAMAS LIMITED（隸屬國際投資機構Global Emerging Markets, GEM）簽署投資合作備忘錄（MOU），擬引進最高新台幣五億元投資額度支持公司新藥研發及營運發展","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：生華科（6492），2026-04-14 14:20，「本公司與GEM YIELD BAHAMAS LIMITED（隸屬國際投資機構Global Emerging Market」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4157-2026-04-14-1401-1vpfi49","company_id":"4157","company":"太景*-KY","market":"上櫃","industry":"生技醫療","date":"2026-04-14","time":"14:01:15","subject":"召開115年股東常會相關事宜(新增報告及討論事項)","clause":"第17款","fact_date":"2026-04-14","cite_as":"公開資訊觀測站重大訊息：太景*-KY（4157），2026-04-14 14:01，「召開115年股東常會相關事宜(新增報告及討論事項)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4168-2026-04-14-0735-dfiixd","company_id":"4168","company":"醣聯","market":"上櫃","industry":"生技醫療","date":"2026-04-14","time":"07:35:43","subject":"本公司ADC新藥GNX1021 獲日本核准啟動人體試驗","clause":"第53款","fact_date":"2026-04-14","cite_as":"公開資訊觀測站重大訊息：醣聯（4168），2026-04-14 07:35，「本公司ADC新藥GNX1021 獲日本核准啟動人體試驗」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}